Product Program year 2025 Source: CMS Open Payments

Modeyso

Drug Hematology/Oncology

NDC 68727-250-01

Open in the dashboard

General payments

$227,848

87 payments

Research payments

$3,232,984

631 payments

Through program year 2025, $227,848 in general payments and $3,232,984 in research payments were reported against Modeyso (Hematology/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $227,848 87
2025 Research $3,232,984 631

Breakdown

Who paid General payments · program year 2025
  1. Jazz Pharmaceuticals Inc. $227,848 87 payments
Top recipients General payments · program year 2025
  1. Amanda Saratsis Neurological Surgery · Park Ridge, IL $143,700 63% · 14 payments
  2. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $50,000 22% · 1 payment
  3. Yazmin Odia Neurology · Miami, FL $15,393 7% · 4 payments
  4. Ashley Sumrall Medical Oncology · Charlotte, NC $2,550 1% · 1 payment
  5. Stephen Bagley Hematology & Oncology · Philadelphia, PA $2,040 <1% · 1 payment

The top 5 of 65 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $145,710 82% · 4 practitioners
  2. Neurology Psychiatry & Neurology $19,855 11% · 8 practitioners
  3. Medical Oncology Internal Medicine $4,769 3% · 8 practitioners
  4. Hematology & Oncology Internal Medicine $4,431 2% · 13 practitioners
  5. Pediatric Hematology-Oncology Pediatrics $1,950 1% · 2 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $143,824 63% · 2 recipients
  2. Michigan $50,000 22% · 1 recipient
  3. Florida $15,844 7% · 16 recipients
  4. Texas $4,006 2% · 4 recipients
  5. North Carolina $3,093 1% · 15 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

87 general · 631 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record